Polycyclic indazole derivatives that are erk inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 231/56 (2006.01) A61K 31/427 (2006.01) A61K 31/428 (2006.01) A61K 31/496 (2006.01) A61K 31/506 (2006.01) A61P 35/00 (2006.01) C07D 403/12 (2006.01) C07D 403/14 (2006.01) C07D 409/12 (2006.01) C07D 413/12 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01)

Patent

CA 2633023

Disclosed are the ERK inhibitors of formula 1.0 and the pharmaceutically acceptable salts and solvates thereof. Q is a piperidine or piperazine ring that can have a bridge or a fused ring. The piperidine ring can have a double bond in the ring. All other substitutents are as defined herein. Also disclosed are methods of treating cancer using the compounds of formula 1Ø

La présente invention concerne des inhibiteurs des kinases régulées par des signaux extracellulaires (ERK) de formule 1.0 et leurs sels et solvates pharmaceutiquement acceptables. Q est un cycle pipéridine ou pipérazine qui peut comporter un cycle fusionné ou un pont. Le cycle pipéridine peut comporter une double liaison. Tous les autres substituants sont tels que définis ici. L'invention concerne également des procédés de traitement du cancer à l'aide des composés de formule 1Ø

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Polycyclic indazole derivatives that are erk inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polycyclic indazole derivatives that are erk inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polycyclic indazole derivatives that are erk inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1947020

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.